Q J Med 2000; 93: 183-190
© 2000 Association of Physicians
Glycaemic control in type 2 diabetes: the impact of body weight, ß-cell function and patient education
From the Diabetes and Endocrine Center, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
Received 19 March 1999 and in revised form 11 January 2000
We examined the determinants of glycaemic control in a consecutive cohort of 562 newly-referred Chinese type 2 diabetic patients (57% women) during a 12-month period. All patients underwent a structured assessment with documentation of clinical and biochemical characteristics. Pancreatic ß-cell function was assessed by fasting plasma C-peptide concentration. Insulin deficiency was defined as fasting plasma C-peptide <0.2 pmol/ml. Insulin resistance (IR) was calculated using the homeostasis model assessment (HOMA) based on a product of fasting plasma glucose and insulin concentrations. Treatment was considered appropriate when insulin-deficient patients were treated with insulin and non-insulin-deficient patients were treated with oral agents or diet. Mean (±SD) age was 54.3±13.8 years (range 17–87 years) and disease duration was 5.0±5.9 years. At the time of referral, 70.5% (n=396) were on drug therapy (9% on insulin and 62.8% on oral agents), 20.6% (n=116) were on diet and 9% (n=50) had not received any form of treatment. The mean HbAlc was 8.4±2.3%. The geometric mean (x/÷ antilog SD) of IR was 4.62x/÷2.51 (range 0.63–162.7) and correlated only with waist : hip ratio (WHR, p=0.008). The geometric mean of plasma C peptide was 0.47x/÷2.89 nmol/l and correlated with BMI (p<0.001). Glycated haemoglobin was correlated positively with age (p=0.013), disease duration (p<0.001), IR (p<0.001) and negatively with BMI (p<0.001). Glycated haemoglobin was lower in patients who had seen a dietitian (7.9% vs. 8.7%, p<0.001) or diabetes nurse (7.8% vs. 8.7%, p<0.001) or who performed self blood glucose monitoring (7.9% vs. 8.6%, p=0.001) and higher among smokers (8.9% vs. 8.2%, p=0.003). Compared to insulin-deficient patients (n=118), non-insulin-deficient patients (n=413) had features resembling that of the Metabolic Syndrome with increased WHR (p=0.005), blood pressure (p<0.001), BMI (p=0.001) and were older (p=0.04). Amongst the insulin-deficient patients, 27% were treated with oral agents or diet. Patients receiving appropriate therapy (n=362) had a lower HbAlc than those treated inappropriately (n=173) (8.2% vs. 8.7%, p=0.02). On multivariate analysis, short disease duration (p<0.001), low IR (p<0.001), high BMI (p=0.001), diabetes education (p<0.001), lack of smoking (p=0.014) and choice of appropriate treatment (p=0.009) were the independent determinants of good glycaemic control.
Address correspondence to Dr W.B. Chan, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin NT, Hong Kong
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. T.C. Ko, W.-Y. So, P. C. Tong, W.-B. Chan, X. Yang, R. C. Ma, A. P. Kong, R. Ozaki, C.-Y. Yeung, C.-C. Chow, et al. Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus Can. Med. Assoc. J., April 28, 2009; 180(9): 919 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. McAndrew, S. H. Schneider, E. Burns, and H. Leventhal Does Patient Blood Glucose Monitoring Improve Diabetes Control?: A Systematic Review of the Literature The Diabetes Educator, November 1, 2007; 33(6): 991 - 1010. [Abstract] [Full Text] [PDF]
|
|